Price
Target price
€71.94
€71.94
-1.130%
-0.82
-1.130%
€124.85
08:01 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
We can see a decrease in the price for Corcept Therapeutics Inc.. Compared to yesterday it has lost -€0.820 (-1.130%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Corcept Therapeutics Inc..
With a target price of 124 € there is a hugely positive potential of 72.37% for Corcept Therapeutics Inc. compared to the current price of 71.94 €.
Our community identified positive and negative aspects for Corcept Therapeutics Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Corcept Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | -1.130% | 5.756% | 17.582% | 25.708% | 46.075% | 207.134% | 273.128% |
| Pacira Pharmaceuticals | 0.000% | 1.000% | 4.663% | 30.323% | 9.189% | -54.091% | -59.274% |
| Rockwell Medical Inc. | 2.130% | 3.742% | -3.427% | -60.305% | -58.061% | -21.713% | -91.735% |
| Twist Bioscience Corp | 3.590% | 3.414% | 7.601% | -43.513% | -38.399% | 4.083% | -73.425% |
Comments
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat